[1] Katsuki H. Exploring neuroprotective drug therapies for intracerebral hemorrhage[J].J Pharmacol Sci, 2010,114(4):366-378.
[2]Nakamura T, Xi G, Park JK, et al. Holo-transferrin and thrombin can interact to cause brain damage[J]. Stroke, 2005,36(2):348-352.
[3]Xi G, Keep RF, Hoff JT. Mechanisms of brain injury after intracerebral hemorrhage[J]. Lancet Neurol, 2006,5(1):53-63.
[4]Ma ChT. The experience of syndrome differentiation and treatment cerebral hemorrhage at acute phase by professor Wang[J]. Sichuan Traditional Chinese Medicine, 2001,19(2):5-6. (in Chinese)
马承泰. 王左教授辨治脑出血急性期经验[J]. 四川中医,2001,19(2):5-6.
[5]Zhou ZhH, Qu F, He X, et al. An improved autologous blood ICH model of rat:double injection and double withdrawal[J].Chinese Journal of Clinical Neurosciences, 2004,12(4):406-408. (in Chinese)
周中和, 曲方, 何祥, 等. 一种改良大鼠自体血脑出血模型:二次注血/退针法[J]. 中国临床神经科学,2004,12(4):406-408.
[6]Longa EZ, Weinstein PR, Carlson S, et al. Reversible middle cerebral artery occlusion without craniectomy in rats[J]. Stroke,1989, 20(1):84-91.
[7]Figueroa BE, Keep RF, Betz AK, et al. Plasminogen activators potentiate thrombin-induced brain injury[J]. Stroke, 1998,29(6):1202-1208.
[8]Xi G, Wagner R, Keep RF, et al. Role of blood clot formation on early edema development following experimental intracerebral hemorrhage[J]. Stroke, 1998,29(12):2580-2586.[9]Coughlin SR. Thrombin signalling and protease-activated receptors[J]. Nature, 2000, 407(6801): 258-264.
[10]Tulinsy A. Molecular interactions of thrombin[J]. Sem in Thromb Hemost, 1996,22(2):117-124.
[11]Fujimoto S, Katsuki H, Kume T, et al. Thrombin-induced delayed injury involves multiple and distinct signaling pathways in the cerebral cortex and the striatum in organotypic slice cultures[J]. Neurobiol Dis, 2006,22(1):130-142.
[12]Ohnishi M, Katsuki H, Fujimoto S, et al. Involvement of thrombin and mitogen-activated protein kinase pathways in hemorrhagic brain injury[J]. Exp Neurol, 2007,206(1):43-52.
[13]Ardizzone TD, Zhan X, Ander BP, et al. SRC kinase inhibition improves acute outcomes after experimental intracerebral hemorrhage[J]. Stroke, 2007,38(5):1621-1625.
[14]Hamill CE, Mannaioni G, Traynelis SF,et al. Protease-activated receptor1-dependent neuronal damage involves NMDA receptor function[J]. Exp Neurol, 2009,217(1):136-146.
[15]Vandell AG, Larson N, Laxmikanthan G, et al. Protease-activated receptor dependent and independent signaling by kallikreins 1 and 6 in CNS neuron and astroglial cell lines[J]. J Neurochem, 2008,107(3):855-870.
[16]Junge CE, Lee CJ, Traynelis SF,et al. Protease-activated receptor-1 in human brain: localization and functional expression in astrocytes[J].Exp Neurol,2004,188(1):94-103.
[17]Wang Y, Richter-Landsberg C, Reiser G. Expression of protease-activated receptors (PARs) in OLN-93 oligodendroglial cells and mechanism of PAR-1-induced calcium signaling[J]. Neuroscience, 2004, 126(1):69-82.
[18]Suo Z, Wu M, Ameenuddin S, et al. Participation of protease-activated receptor-1 in thrombin-induced microglial activation[J]. J Neurochem, 2002,80(4):655-666.
[19]Bartha K, Domotor E, Lanza F, et al. Identification of thrombin receptors in rat brain capillary endothelial cells[J]. J Cereb Blood Flow Metab, 2000, 20(1):175-182.
[20]Ma ChT, Jiang YX, Wang Z. Experimental study of the protect effect of Xingnaojing-shengmai decoction on the cortical astrocytes injurying by thrombin[J]. Chinese Journal of Integrated Traditional and Western Medicine in Intensive and Critical Care, 2003,10(1):46-48. (in Chinese)
马承泰,蒋艳霞,王左.醒脑静生脉混合液对凝血酶损伤星形胶质细胞的保护作用[J]. 中国中西医结合急救杂志, 2003,10(1):46-48. |